Life Science Leader Magazine

NOV 2014

The vision of Life Science Leader is to help facilitate connections and foster collaborations in pharma and med device development to get more life-saving and life-improving therapies to market in an efficient manner. Connect, Collaborate, Contribute

Issue link:

Contents of this Issue


Page 0 of 53

We deliver more science noun / 'sīә ns/ 1: LabCorp Clinical Trials delivers high quality and cutting-edge science in multiple areas – such as biomarker development, flow cytometry, and companion diagnostics (CDx). 2: We also provide a number of core genomic services to our clients – including mutation analysis, pharmacogenetics and pharmacogenomics – from our global locations in North America, Belgium, Singapore and China to support early to late phase clinical trials. 3: LabCorp recently acquired the Covance Genomics Laboratory and its associated genomic analysis business located in Seattle. 6JKUUVCVGQHVJGCTVNCDQTCVQT[JCUUKIPKƂECPVN[ expanded our offering by allowing LabCorp to provide leading-edge complex genomic analysis – including gene expression array studies, biomarker translation, and next generation sequencing applications. 4: As a result, LabCorp is now one of the few global providers offering such a comprehensive portfolio of core and advanced genomic services, supporting clients from preclinical and early stage to late stage drug development. Visit our website to learn more about LabCorp's extensive service portfolio as a global leader in biomarker testing. LabCorp's advanced genomics laboratory in Seattle, WA

Articles in this issue

Links on this page

Archives of this issue

view archives of Life Science Leader Magazine - NOV 2014